Stef De Lombaerde
Antwerpen, VLG 2610, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction to "Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates".
Journal: Journal of medicinal chemistry
Published: September 26, 2025
Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates.
Journal: Journal of medicinal chemistry
Published: July 07, 2025
Preclinical evaluation of [11C]CHDI-009R for quantification of mutant huntingtin aggregates.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: June 04, 2025
Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model.
Journal: Neurobiology of disease
Published: January 24, 2025
Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 22, 2024
First-in-human study of a novel cell death tracer [99mTc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers.
Journal: EJNMMI radiopharmacy and chemistry
Published: July 24, 2023
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.
Journal: Science translational medicine
Published: February 02, 2022
Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [11C]ABP688 and [18F]FPEB Positron Emission Tomography in the Sapap3 Knockout Mouse Model for Obsessive-Compulsive-like Behavior.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: June 25, 2021
Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11C]UCB-J PET study in a model of obsessive-compulsive disorder-like behaviour.
Journal: EJNMMI research
Published: July 24, 2020
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.
Journal: EJNMMI radiopharmacy and chemistry
Published: June 02, 2020
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine.
Journal: Nuclear medicine and biology
Published: November 08, 2019
In Vivo Measurement of Hepatic Drug Transporter Inhibition with Radiolabeled Bile Acids.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 25, 2019
Last Updated: 09/26/2026